AUDA-NEPAD Emphasizes Potential of AfCFTA to Building Robust Pharmaceutical Industry in Africa

0
AUDA-NEPAD Emphasizes Potential of AfCFTA to Building Robust Pharmaceutical Industry in Africa
AUDA-NEPAD Emphasizes Potential of AfCFTA to Building Robust Pharmaceutical Industry in Africa

Africa-Press – Ethiopia. Addressing the G20 High-Level Meeting on the African Continental Free Trade Area (AfCFTA) and pharmaceutical industrialization, Nardos Bekele-Thomas, CEO of AUDA-NEPAD emphasized the potential of the AfCFTA to serve as a cornerstone for building a robust pharmaceutical industry in Africa.

Her remarks painted a vivid picture of both the urgency and opportunity facing Africa amidst a shifting global landscape.

She declared, “The era of business as usual cannot continue. Development must be reimagined, rooted in self-reliance, economic sovereignty, and transformative investments.”

The CEO called for a unified health ecosystem, addressing inefficiencies in procurement and regulation to meet the continent’s healthcare needs.

Despite the challenges, she celebrated Africa’s resilience and innovation citing the continent’s response to the COVID-19 pandemic as a testament to its collective strength. From drone delivery systems in Rwanda to expanding telemedicine in Kenya, Africa has demonstrated its capability to address local health needs creatively.

AUDA-NEPAD’s Southern Africa Network for Biosciences (SANBio) has been pivotal in advancing natural African traditional medicine. Collaborative efforts between universities, science councils, and pharmaceutical companies have already led to significant developments.

In her address, Nardos outlined AUDA-NEPAD’s strategy to industrialise Africa’s pharmaceutical sector.

This agenda extends beyond medicine production, aiming to create a continental economy rooted in dignity, resilience, and justice.

Key initiatives include the 24 Priority Medical Products Initiative, which focuses on scaling up domestic production of critical medicines, and the African Medicines Regulatory Harmonization Programme (AMRH), which has streamlined regulatory processes to enable cross-border trade under AfCFTA.

Nardos also highlighted the Programme for Investment and Financing in Africa’s Health Sector (PIFAH), aimed at mobilizing resources, fostering innovation, and advancing African-led medical discoveries.

“Africa cannot produce at scale if buyers are fragmented, and procurement is unpredictable,” she cautioned, endorsing the Africa CDC-led African Pooled Procurement Mechanism.

Nardos called on political leaders, financiers, and stakeholders to unite in aligning health and industrial agendas.

The CEO concluded by aligning her vision with South Africa’s G20 Presidency theme of “Building towards an inclusive and sustainable recovery.”

She urged collective action to ensure that Africa’s health solutions are driven by African ingenuity and industry.

“This is our moment to ensure that the value chains powering Africa’s growth are rooted in our innovation,” she declared, leaving the audience with a resounding sense of urgency and purpose.

For More News And Analysis About Ethiopia Follow Africa-Press

LEAVE A REPLY

Please enter your comment!
Please enter your name here